Papua New Guinea

Reimbursed Care Access

Papua New Guinea maintains a conventional, restrictive approach to classical psychedelics: most classical psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, 2C‑X, ibogaine and ayahuasca preparations) are effectively controlled and have no authorised medical/reimbursement pathway outside approved research. Ketamine is widely used as an essential anaesthetic across PNG health facilities, whereas esketamine (Spravato) has no documented national regulatory listing or routine reimbursement pathway in PNG.